Public BoD papers 26.5.22

5. Well-Led

5.1 - Finance (Executive Summary)

YTD Budget YTD Actual

Variance

£'000

£'000

£'000

This report outlines the consolidated financial performance of The Christie NHS Foundation Trust and its wholly owned subsidiary The Christie Pharmacy Ltd.

NHS Clinical - Block Contract Income

(27,064)

(26,409)

656 (13)

NHS Clinical Income

(584)

(597) (105)

Charitably funded capital donations

0 0

(105)

Donated CEF grant income Other non clinical income

0

0

(4,932) (32,580) 15,595 8,280 7,225 31,100 (1,481)

(4,597) (31,707) 14,431 8,276 7,133 29,840 (1,867)

335 873

Income

Pay

(1,163)

I&E • The trust is reporting a month 1 position of £266k deficit compared to a £220k deficit plan within the latest plan submission of an annual control total deficit of £2.6m. • The month 1 EBITDA position is a surplus of £1,867k • The month 1 I&E deficit is £1,709k, prior to adjusting for donated depreciation, charitably funded capital donations, donated grant income, donated consumables, transfers by absorption and impairments. • 2022-23 CIP - £1.9m has been identified at this stage against a 22/23 CIP plan of £11.8m Balance sheet / liquidity • The cash balance is £151,638k. • Debtor days reduced from 12 to 10 days from the previous month. • Capital expenditure is 39% below the NHSI plan reflecting the Paterson and VAT. Other • No profit from TCPC is realised at month1 22-23 and is not expected until TCPC have generated their contractual agreed value, in line with previous

Drugs

(4)

Other non pay

(92)

Total expenditure

(1,260)

EBITDA

(387)

Non operating income Non operating expenditure

(479) 3,741 1,781

(166) 3,742 1,709

313

2

(Surplus) / Deficit Exclude impairments

(72)

(1,167)

(1,167)

0

Exclude charitably funded capital donations Exclude donated CEF grant income

0 0 0 0 0

105

105

0

0

Exclude donated depreciation

(394)

(381)

13

Exclude consumables donated from DHSC

0 0 0

0 0 0

Exclude contributions to expenditure - inventory donated Exclude gains/(losses) from transfers by absorption Adjusted financial performance (surplus) / deficit

220

266

46

years this is to be expected in quarter 3 of this year. • 30 day PSPP is at 99% for trade and 100% NHS.

56

33